SCHEMBL30824705

SCHEMBL30824705

CCSc1nc(N2CCOCC2)cc(C)c1C(=O)NCCCC(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
GAA P10253 3/20 0.42
HPGD P15428 3/20 0.42
HSD17B10 Q99714 3/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP3A4 P08684 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GLA P06280 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NAPEPLD Q6IQ20 3/20 0.39
RAF1 P04049 9/20 0.38
BRAF P15056 8/20 0.38
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2127971 1.00 ALDH1A1 (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL2133126 0.94 KDM4E (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL30794972 0.94 KDM4E (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL2129392 0.94 KDM4E (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL2134391 0.91 RAB9A (0.43) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL2129040 0.91 RAB9A (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL2130664 0.90 ALDH1A1 (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL30795329 0.90 ALDH1A1 (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL2131119 0.90 ALDH1A1 (0.51) ALDH1A1GAAHPGDHSD17B10KDM4E
SCHEMBL2130364 0.90 RAB9A (0.42) ALDH1A1GAAHPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054807-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND TDP-43 MODULATORS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-03-14 WO disclosed